https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-23 / PLoS ONE 2009;4(1):e4256
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-23 / PLoS ONE 2009;4(1):e42562009-01-23 00:00:002019-02-15 09:15:04In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-20 / J. Dermatol. Sci. 2009 Apr;54(1):31-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-20 / J. Dermatol. Sci. 2009 Apr;54(1):31-72009-01-20 00:00:002019-02-15 08:49:30Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-17 / Virus Res. 2009 Apr;141(1):13-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-17 / Virus Res. 2009 Apr;141(1):13-202009-01-17 00:00:002019-02-15 09:21:56Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-472009-01-16 00:00:002019-02-15 09:17:36Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-15 / Cancer 2009 Jan;115(2):311-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-15 / Cancer 2009 Jan;115(2):311-232009-01-15 00:00:002019-02-15 09:17:38Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-642009-01-13 00:00:002019-02-15 08:44:20Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-522009-01-12 00:00:002019-02-15 08:49:55Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-672009-01-09 00:00:002019-02-15 08:44:28Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Drugs 2009;69(3):241-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Drugs 2009;69(3):241-92009-01-01 00:00:002019-02-15 08:46:48Tumour vaccine approaches for CNS malignancies: progress to date
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Hepatology 2009 Jan;49(1):124-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Hepatology 2009 Jan;49(1):124-322009-01-01 00:00:002020-01-08 10:10:21A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
